Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Cannabis in Chronic Spine Pain
NCT05052541Phase 3Recruiting
- Sponsor
- University of Colorado Denver
- Start
- Jan 2026
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dronabinol, Tilray FS Oral Solution in back pain, Cervicalgia, sponsored by University of Colorado Denver. Started Jan 2026; status: recruiting.
02
Drugs
dronabinolTilray FS Oral Solution
03
Conditions
back painCervicalgia
Beyond the preview
Go deeper on NCT05052541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05052541.